Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martha Nason

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
Plos One|April 13, 2012
Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccinationCheng Cheng, Lingshu Wang, LingShu Wang, et al.
Journal of Virology|November 20, 2009
Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variablesNicole A Doria-Rose, Rachel M Klein, Marcus G Daniels, et al.
Blood|March 15, 2011
Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infectionTakuya Yamamoto, David A Price, Joseph P Casazza, et al.
Science Translational Medicine|July 5, 2019
Design of vaccine efficacy trials during public health emergenciesNatalie E Dean, Pierre-Stéphane Gsell, Ron Brookmeyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2021
PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male SurvivorsElizabeth S Higgs, Dehkontee Gayedyu-Dennis, William A Fischer Ii, et al.
Open Forum Infectious Diseases|October 27, 2025
Herpesviruses Reactivation and Systemic Inflammation Before and After Initiating Antiretroviral Therapy Among Women with HIV in Rakai, UgandaVictor Ssempijja, Viviane Callier, Martha Nason, et al.
Plos One|March 19, 2009
Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and miceSrinivas Rao, Wing-Pui Kong, Chih-Jen Wei, et al.
Journal of Virology|October 17, 2008
Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodiesNicole A Doria-Rose, Rachel M Klein, Maura M Manion, et al.
Pathogens & Immunity|April 18, 2019
Susceptibility to SIV Infection After Adenoviral Vaccination in a Low Dose Rhesus Macaque Challenge ModelIrene Bukh Brody, Roberto Calcedo, Mary J Connell, et al.
Clinical Trials (London, England)|July 22, 2022
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threatsIra M Longini, Yang Yang, Thomas R Fleming, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Plos One|April 13, 2012
Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccinationCheng Cheng, Lingshu Wang, LingShu Wang, et al.
Journal of Virology|November 20, 2009
Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variablesNicole A Doria-Rose, Rachel M Klein, Marcus G Daniels, et al.
Blood|March 15, 2011
Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infectionTakuya Yamamoto, David A Price, Joseph P Casazza, et al.
Science Translational Medicine|July 5, 2019
Design of vaccine efficacy trials during public health emergenciesNatalie E Dean, Pierre-Stéphane Gsell, Ron Brookmeyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2021
PREVAIL IV: A Randomized, Double-Blind, 2-Phase, Phase 2 Trial of Remdesivir vs Placebo for Reduction of Ebola Virus RNA in the Semen of Male SurvivorsElizabeth S Higgs, Dehkontee Gayedyu-Dennis, William A Fischer Ii, et al.
Open Forum Infectious Diseases|October 27, 2025
Herpesviruses Reactivation and Systemic Inflammation Before and After Initiating Antiretroviral Therapy Among Women with HIV in Rakai, UgandaVictor Ssempijja, Viviane Callier, Martha Nason, et al.
Plos One|March 19, 2009
Multivalent HA DNA vaccination protects against highly pathogenic H5N1 avian influenza infection in chickens and miceSrinivas Rao, Wing-Pui Kong, Chih-Jen Wei, et al.
Journal of Virology|October 17, 2008
Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodiesNicole A Doria-Rose, Rachel M Klein, Maura M Manion, et al.
Pathogens & Immunity|April 18, 2019
Susceptibility to SIV Infection After Adenoviral Vaccination in a Low Dose Rhesus Macaque Challenge ModelIrene Bukh Brody, Roberto Calcedo, Mary J Connell, et al.
Clinical Trials (London, England)|July 22, 2022
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threatsIra M Longini, Yang Yang, Thomas R Fleming, et al.
Pageof 8